Therapy and prevention for mental health: What if mental diseases are mostly not brain disorders?
- 6 March 2019
- journal article
- editorial
- Published by Cambridge University Press (CUP) in Behavioral and Brain Sciences
- Vol. 42, e13
- https://doi.org/10.1017/s0140525x1800105x
Abstract
Neurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.Keywords
This publication has 10 references indexed in Scilit:
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisThe Lancet, 2018
- What causes psychosis? An umbrella review of risk and protective factorsWorld Psychiatry, 2018
- Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in EuropeDrug and Alcohol Dependence, 2017
- Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy PredictorsAmerican Journal of Psychiatry, 2017
- Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic surveyEuropean Journal of Internal Medicine, 2016
- Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adultsCochrane Database Of Systematic Reviews, 2015
- Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric DisordersJAMA Psychiatry, 2014
- Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs)Trials, 2014
- Something's got to give: psychiatric disease on the rise and novel drug development on the declineDrug Discovery Today, 2013
- Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?Philosophy, Ethics, and Humanities in Medicine, 2008